DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Lomustine
Lomustine
Cancer Drug Pharmacology Table
The Synergic Effect of Vincristine and Vorinostat in Leukemia in Vitro and In
List of Drugs Not Repackaged by Safecor Health
How Chemotherapy Drugs Work
The Antitumor Effects of an Arsthinol–Cyclodextrin Complex in A
Chemotherapy Medications
Therapeutic Options in Recurrent Glioblastoma – an Update
Interstitial Photodynamic Therapy Using 5-ALA for Malignant Glioma Recurrences
Current FDA-Approved Therapies for High-Grade Malignant Gliomas
In Vitro Elucidation of the Metabolic Fate of the Anticancer Drug Busulfan
The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma
Cancer Drug Costs for a Month of Treatment at Initial Food
Bace-Bendamustine, Cytarabine, Cyclophosphamide and Etoposide) in Patients with Lymphoma Undergoing Autologous Stem Cell Transplant
Promising Survival for Patients with Glioblastoma Multiforme Treated with Individualised Chemotherapy Based on in Vitro Drug Sensitivity Testing
©Ferrata Storti Foundation
NTP Monograph on the Systematic Review of Occupational Exposure to Cancer Chemotherapy Agents and Adverse Health Outcomes
EPHB Report No. 380-15A Animal Specialty & Emergency Center
Clinical Trial Protocol
Top View
CNBEV Protocol
Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
Clinically Relevant Concentrations of Anticancer Drugs: a Guide for Nonclinical Studies Dane R
DRUG NAME: Lomustine
Ceenu Product Monograph
Therapeutic Options in Recurrent Glioblastoma – an Update Katharina
Medications That Are Immunosuppressive Or Immunomodulatory (This List Is Not All-Inclusive)
Emetogenic Potential of Antineoplastic Agents
Fluorescence-Guided High-Grade Glioma Surgery More Than Four Hours After 5-Aminolevulinic Acid Administration
Recurrent Glioblastoma: from Molecular Landscape to New Treatment Perspectives
Adult Antiemetic Management of Chemotherapy-Induced Nausea
List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
High-Dose Methotrexate-Based Immuno-Chemotherapy for Elderly Primary CNS Lymphoma Patients (PRIMAIN Study)
Combination of ALA-Induced Fluorescence-Guided Resection And
Salvage Chemotherapy for Oligodendroglioma
Enhanced Anticancer Properties of Lomustine in Conjunction with Docosahexaenoic Acid in Glioblastoma Cell Lines
BRAIN CANCER TREATMENT REGIMENS (Part 1 of 9) Clinical Trials: the NCCN Recommends Cancer Patient Participation in Clinical Trials As the Gold Standard for Treatment
Clinical Challenges in Caring for Patients with Diabetes and Cancer
Lomustine and Temozolomide for Newly Diagnosed Glioblastoma with Methylated MGMT Promoter: Lessons from the Ceteg/NOA- 09 Trial
DECC (Relapsed and Progressive Hodgkin and Non Hodgkin Lymphoma)
Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients
Inhibition of Malignant Glial Cell Growth by Estramustine, an Estrogen
'How Did Lomustine Become Standard of Care In
DRUG NAME Toxicities: Acute: Delayed: Subclass Mechanism of Action
Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
Metabolism of Lomustine in Dogs and Comparative
Rapid On-Demand Synthesis of Lomustine Under Continuous Flow Conditions Zinia Jaman,† Tiago J
GLEOSTINE Safely and Effectively
NIOSH Alert: Preventing Occupational Exposures to Antineoplastic
Exploiting Nucleophilic Attack in Chemotherapy Pooja Venkatesh Agnes Scott College
Clinical and Pharmacologie Effects of High Dose Single Agent Busulfan with Autologous Bone Marrow Support in the Treatment of Solid Tumors W
LOMUSTINE - Lomustine Capsule, Gelatin Coated Nextsource Biotechnology, LLC
Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections Valerie W. C. Soo1£, Brian W. Kwan 1£, Héctor Queza
Hazardous Drug List
Ovarian Function After Autologous Bone Marrow Transplantation in Childhood: High-Dose Busulfan Is a Major Cause of Ovarian Failure
Overview of Dual-Acting Drug Methotrexate in Different
Full Prescribing Information for Recurrent Glioblastoma (2.4) AVASTIN
Second-Line Therapy for Disseminated Small-Cell Lung Cancer: Optimal Management Remains to Be Defined
Antineoplastic Drugs